Journal of Orthopedics and Joint Surgery

Register      Login

VOLUME 6 , ISSUE 1 ( January-June, 2024 ) > List of Articles

CASE REPORT

A Case of Xanthoma of Bilateral Tendoachilles Reconstructed with Fascia Lata Graft X

S Jaikish, Balaji Sambandam

Keywords : Case report, Cerebrotendinous xanthomatosis, Fascia lata, Tendoachilles, Xanthoma

Citation Information : Jaikish S, Sambandam B. A Case of Xanthoma of Bilateral Tendoachilles Reconstructed with Fascia Lata Graft X. 2024; 6 (1):79-81.

DOI: 10.5005/jojs-10079-1124

License: CC BY-NC 4.0

Published Online: 12-01-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Aims and background: Cerebrotendinous xanthoma is an autosomal recessive disorder characterized by a lack of production of primary bile acids and accumulation of cholestanol in various tissues like the brain, spinal cord, peripheral nerves, eyes, and tendon in the form of xanthomas. This is a case report of one such patient who had xanthoma of both tendoachilles. Case description: A 30-year-old female patient had swelling in both legs. Gradually, it became painful while walking. On examination, she had a swelling of size 10 by 4 cm attached to tendoachilles. Magnetic resonance imaging (MRI) showed features of xanthoma. Staged surgery was done. The mass was fleshy and pale yellow and replaced the entire tendon. The entire mass was removed, creating a defect of about 20 cm. Fascia lata of size 20 by 6 cm was harvested and made into a fourstrand graft. Proximally, it was sutured with fiber wires to the distal part of the muscle. Distally, it was fixed to the calcaneum using a 5 mm suture anchor. Flexor hallucis longus (FHL) tendon was used to augment the reconstruction. At 1 year, she was asymptomatic and gained good strength and ROM in the ankle. Conclusion and clinical significance: Cerebrotendinous xanthoma causes impairment in joint mobility and ambulation. Deposition of cholestanol in the neurons causes atrophy and secondary demyelination. Simple excision of tendoachilles xanthoma will do more harm to the patient who is more prone to neurological and mobility-related issues. Fascia lata graft has the advantage of limited donor site morbidity and adequate length.


PDF Share
  1. Kuri yama M, Fuji yama J, Yoshidome H, et al. Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of eight patients and review of the literature. J Neurol Sci 1991;102:225–232. DOI: 10.1016/0022-510x(91)90073-g
  2. Berginer VM, Berginer J, Korczym AD, et al. Magnetic resonance imaging in CTX: a prospective clinical and neuroradiological study. J Neurol Sci 1994;122:102–108. DOI: 10.1016/0022-510x(94)90059-0
  3. Oftebro H, Björkhem I, Skrede S, et al. Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid. J Clin Invest 1980;65(6): 1418–1430. DOI: 10.1172/JCI109806
  4. Menkes JH, Schimschock JR, Swanson PD. Cerebrotendinous xanthomatosis. The storage of cholestanol within the nervous system. Arch Neurol 1968;19(1):47–53. DOI: 10.1001/archneur.1968.00480010065004
  5. Salen G. Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism. Ann Intern Med 1971;75(6):843–851. DOI: 10.7326/0003-4819-75-6-843
  6. Dotti MT, Federico A. Cerebrotendinous xanthomatosis as a multisystem disease mimicking premature ageing. Dev Neurosci 1991;13(4-5):371–376. DOI: 10.1159/000112187
  7. Gallus GN, Dotti MT, Federico A. Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. Neurol Sci 2006;27(2):143–149. DOI: 10.1007/s10072-006-0618-7
  8. Berlin SJ. Statistical analysis of 307,601 tumors and other lesions of the foot. J Am Podiatr Med Assoc 1995;85:699–703. DOI: 10.7547/87507315-85-11-699
  9. Ozdemir HM, Yildiz Y, Yilmaz C, et al. Tumors of the foot and ankle: analysis of 196 cases. J Foot Ankle Surg 1997;36:403–408. DOI: 10.1016/s1067-2516(97)80089-0
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.